Interleukin-17 (IL-17), the prototype cytokine produced by the Th17 subset of T-helper cells, plays a role in inflammatory responses, autoimmunity, and antimicrobial responses in a variety of infectious and inflammatory diseases. In view of the inflammatory nature and severity of aggressive periodontitis, we hypothesized that IL-17 might be detected in sera from patients with aggressive periodontitis. We used ELISA to measure IL-17 serum concentrations from 67 periodontally healthy (NP) individuals and from 53 patients with localized (LAgP) and 49 patients with generalized (GAgP) aggressive periodontitis. IL-17 was barely detectable in sera from periodontally healthy individuals (1.9 ± 2.0 pg/mL), but was present at significantly higher concentrations in sera from those with LAgP (7.6 ± 2.2 pg/mL) and GAgP (17.1 ± 2.3 pg/mL). Multivariate analyses demonstrated associations of IL-17 concentrations with periodontal attachment loss, but not with current smoking. Therefore, Th17 responses may be characteristic of AgP, and IL-17 may play a role in the pathogenesis of aggressive periodontitis.
BeklenAAinolaMHukkanenMGurganCSorsaTKonttinenYT (2007). MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res86:347-351.
2.
BorchTSLobnerMBendtzenKHolmstrupPNielsenCH (2009). Decreased interleukin-2 responses to Fusobacterium nucleatum and Porphyromonas gingivalis in generalized aggressive periodontitis. J Periodontol80:800-887.
3.
CardosoCRGarletGPCrippaGERosaALJuniorWMRossiMA. (2009). Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol24:1-6.
4.
ChenYWIwaiTUmedaMNagasawaTHuangYTakeuchiY. (2007). Elevated IgG titers to periodontal pathogens related to Buerger disease. Int J Cardiol122:79-81.
5.
ChenYWNagasawaTWara-AswapatiNUshidaYWangDTakeuchiY. (2009). Association between periodontitis and anti-cardiolipin antibodies in Buerger disease. J Clin Periodontol36:830-835.
6.
De-GennaroLALopesJDMarianoM (2006). Autoantibodies directed to extracellular matrix components in patients with different clinical forms of periodontitis. J Periodontol77:2025-2030.
7.
DutzanNGamonalJSilvaASanzMVernalR (2009). Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis. J Clin Periodontol36:396-403.
8.
FujinoSAndohABambaSOgawaAHataKArakiY. (2003). Increased expression of interleukin 17 in inflammatory bowel disease. Gut52:65-70.
9.
GaffenSLHajishengallisG (2008). A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res87:817-828.
10.
HermanSKronkeGSchettG (2008). Molecular mechanisms of inflammatory bone damage: emerging targets for therapy. Trends Mol Med14:245-253.
11.
HondaTAokiYTakahashiNMaekawaTNakajimaTItoH. (2008). Elevated expression of IL-17 and IL-12 genes in chronic inflammatory periodontal disease. Clin Chim Acta395:137-141.
12.
ItoHHondaTDomonHOdaTOkuiTAmanumaR. (2005). Gene expression analysis of the CD4+ T-cell clones derived from gingival tissues of periodontitis patients. Oral Microbiol Immunol20:382-386.
13.
JohnsonRBWoodNSerioFG (2004). Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol75:37-43.
14.
KoutouzisTHaberDShaddoxLAukhilIWalletSM (2009). Autoreactivity of serum immunoglobulin to periodontal tissue components: a pilot study. J Periodontol80:625-633.
15.
LesterSRBainJLJohnsonRBSerioFG (2007). Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. J Periodontol78:1545-1550.
16.
LöeHBrownLJ (1991). Early onset periodontitis in the United States of America. J Periodontol62:608-616.
17.
LöeHSilnessJ (1963). Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand21:533-551.
18.
MahanondaRJitprasertwongPSa-Ard-IamNRerkyenPCharatkulangkunOJansisyanontP. (2008). Effects of IL-17 on human gingival fibroblasts. J Dent Res87:267-272.
19.
MühlemannHRSonS (1971). Gingival sulcus bleeding: a leading symptom in initial gingivitis. Helv Odontol Acta15:107-113.
20.
OdaTYoshieHYamazakiK (2003). Porphyromonas gingivalis antigen preferentially stimulates T cells to express IL-17 but not receptor activator of NF-kappaB ligand in vitro. Oral Microbiol Immunol18:30-36.
21.
OhyamaHKato-KogoeNKuharaANishimuraFNakashoKYamanegiK. (2009). The involvement of IL-23 and the Th17 pathway in periodontitis. J Dent Res88:633-638.
22.
RajapaksePSDolbyAE (2004). Evidence for local production of antibodies to auto and non-self antigens in periodontal disease. Oral Dis10:99-105.
23.
RuddyMJShenFSmithJBSharmaAGaffenSL (2004). Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol76:135-144.
24.
SatoKSuematsuAOkamotoKYamaguchiAMorishitaYKadonoY. (2006). Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med203:2673-2682.
25.
SchenkeinHAVan DykeTE (1994). Early-onset periodontitis: systemic aspects of etiology and pathogenesis. Periodontol 20006:7-25.
26.
SchenkeinHABerryCRBurmeisterJABrooksCNBarbourSEBestAM. (2003). Anti-cardiolipin antibodies in sera from patients with periodontitis. J Dent Res82:919-922.
27.
SchenkeinHABestAMBrooksCNBurmeisterJAArrowoodJAKontosMC. (2007). Anti-cardiolipin and increased serum adhesion molecule levels in patients with aggressive periodontitis. J Periodontol78:459-466.
28.
SilnessJLöeH (1964). Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand22:121-135.
29.
TakahashiKAzumaTMotohiraHKinaneDFKitetsuS (2005). The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol32:369-374.
30.
TesmerLALundySKSarkarSFoxDA (2008). Th17 cells in human disease. Immunol Rev223:87-113.
31.
VernalRDutzanNChaparroAPuenteJValenzuelaMAGamonalJ (2005). Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol32:383-389.
32.
YuJJGaffenSL (2008). Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci13:170-177.
33.
YuJJRuddyMJWongGCSfintescuCBakerPJSmithJB. (2007). An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood109:3794-3802.
